Project Details
| Status | Active |
|---|---|
| Effective start/end date | 04/7/22 → 08/1/27 |
Funding
- AstraZeneca Pharmaceuticals LP: $98,345.45
TITANIA: A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallelgroup, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 in Participants with Symptomatic Chronic Obstructive
- Sethi, Sanjay (PI)
Project: Research